Skip to main content

FDA recall, , Moderate risk

Nuclein DASH Rapid PCR Instrument

The DASH Rapid PCR Instrument has a software issue.

What happened

Nuclein LLC of Austin, Texas recalled the DASH Rapid PCR Instrument, model SG-0002, with software versions 6.0.2, 6.0.4, 6.0.5, and 6.0.6, due to a software issue. The recall began on October 22, 2025, and was listed in states including Alabama, Delaware, Florida, Georgia, Kansas, Massachusetts, Maryland, Maine, Michigan, North Carolina, New York, Ohio, South Carolina, Tennessee, Texas, Virginia, and Vermont.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the list below, then check the codes the FDA notice also names.

  1. DASH Rapid PCR Instrument

    Model number
    • SG-0002

From the FDA notice

Brand Name: DASH Rapid PCR Instrument Product Name: DASH Rapid PCR Instrument Model/Catalog Number: SG-0002 Software Version: 6.0.2, 6.0.4, 6.0.5, 6.0.6 Product Description: The DASH¿ Rapid PCR Instrument (DASH Instrument) is an automated, fluorescence-based, reverse-transcription polymerase chain reaction (RT-PCR) instrument that extracts specimens and performs nucleic acid amplified tests (NAAT) in DASH test cartridges for the qualitative detection of infectious diseases.

Recall details

Company began the recall
Company
Nuclein LLCAustin, Texas
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99356
Recall number
Z-3164-2026

All recalls from Nuclein LLC

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)